No abstract available
MeSH terms
-
Antineoplastic Agents / pharmacology
-
Antineoplastic Agents / therapeutic use*
-
Clinical Trials as Topic
-
Clinical Trials, Phase I as Topic
-
Drug Approval
-
Drug Design
-
Enzyme Inhibitors / pharmacology
-
Histone Deacetylase Inhibitors
-
Humans
-
Hydroxamic Acids / pharmacology
-
Hydroxamic Acids / therapeutic use*
-
Lymphoma, T-Cell, Cutaneous / drug therapy*
-
Skin Neoplasms / drug therapy*
-
United States
-
United States Food and Drug Administration
-
Vorinostat
Substances
-
Antineoplastic Agents
-
Enzyme Inhibitors
-
Histone Deacetylase Inhibitors
-
Hydroxamic Acids
-
Vorinostat